NBY logo

NovaBay Pharmaceuticals (NBY) Long Term Debt

NBY Annual Long Term Debt

$1.11 M
-$480.00 K-30.23%

01 December 2023

NBY Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBY Quarterly Long Term Debt

$821.00 K
-$111.00 K-11.91%

01 September 2024

NBY Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBY Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-30.2%-34.0%
3 y3 years+1173.6%-40.5%
5 y5 years+100.0%-40.5%

NBY Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-30.2%+350.4%-57.3%+233.7%
5 y5-year-30.2%+1173.6%-57.3%>+9999.0%
alltimeall time-33.0%-77.5%

NovaBay Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sept 2024
-
$821.00 K(-11.9%)
June 2024
-
$932.00 K(-10.5%)
Mar 2024
-
$1.04 M(-6.0%)
Dec 2023
$1.11 M(-30.2%)
$1.11 M(-10.9%)
Sept 2023
-
$1.24 M(-9.8%)
June 2023
-
$1.38 M(-8.8%)
Mar 2023
-
$1.51 M(-4.8%)
Dec 2022
$1.59 M(+545.5%)
$1.59 M(-7.3%)
Sept 2022
-
$1.71 M(-4.8%)
June 2022
-
$1.80 M(-6.3%)
Mar 2022
-
$1.92 M(+681.3%)
Dec 2021
$246.00 K(+182.8%)
$246.00 K(>+9900.0%)
Sept 2021
-
$1000.00(-80.0%)
June 2021
-
$5000.00(-44.4%)
Mar 2021
-
$9000.00(-89.7%)
Dec 2020
$87.00 K(-82.8%)
$87.00 K(-55.8%)
Sept 2020
-
$197.00 K(-35.0%)
June 2020
-
$303.00 K(-25.4%)
Mar 2020
-
$406.00 K(-19.6%)
Dec 2019
$505.00 K
$505.00 K(-19.5%)
DateAnnualQuarterly
Sept 2019
-
$627.00 K(-82.8%)
June 2019
-
$3.65 M(+54.1%)
Mar 2019
-
$2.37 M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
June 2016
-
$524.00 K(-82.9%)
Mar 2016
-
$3.06 M(+85.1%)
Dec 2015
$1.66 M(+1461.3%)
$1.66 M(+3840.5%)
Mar 2010
-
$42.00 K(-60.4%)
Dec 2009
$106.00 K(-77.8%)
$106.00 K(-36.9%)
Sept 2009
-
$168.00 K(-38.0%)
June 2009
-
$271.00 K(-27.2%)
Mar 2009
-
$372.00 K(-22.0%)
Dec 2008
$477.00 K(-12.6%)
$477.00 K(-18.2%)
Sept 2008
-
$583.00 K(-15.1%)
June 2008
-
$687.00 K(+11.3%)
Mar 2008
-
$617.00 K(+13.0%)
Dec 2007
$546.00 K
$546.00 K(+46.4%)
Sept 2007
-
$373.00 K(-10.6%)
June 2007
-
$417.00 K(+441.6%)
Mar 2007
-
$77.00 K

FAQ

  • What is NovaBay Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals annual long term debt year-on-year change?
  • What is NovaBay Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals quarterly long term debt year-on-year change?

What is NovaBay Pharmaceuticals annual long term debt?

The current annual long term debt of NBY is $1.11 M

What is the all time high annual long term debt for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high annual long term debt is $1.66 M

What is NovaBay Pharmaceuticals annual long term debt year-on-year change?

Over the past year, NBY annual long term debt has changed by -$480.00 K (-30.23%)

What is NovaBay Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of NBY is $821.00 K

What is the all time high quarterly long term debt for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high quarterly long term debt is $3.65 M

What is NovaBay Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, NBY quarterly long term debt has changed by -$423.00 K (-34.00%)